scholarly article | Q13442814 |
P2093 | author name string | Leigh Brian | |
Lisheng Zhang | |||
Neil J Freedman | |||
Karsten Peppel | |||
Eric S Orman | |||
Perumal Sivashanmugam | |||
Sabrina T Exum | |||
P2860 | cites work | Acute-phase proteins and other systemic responses to inflammation | Q28296941 |
NF-kappaB: pivotal mediator or innocent bystander in atherogenesis? | Q28346544 | ||
A major role for VCAM-1, but not ICAM-1, in early atherosclerosis | Q28365883 | ||
Inflammation, atherosclerosis, and coronary artery disease | Q29547232 | ||
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men | Q29619308 | ||
Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions | Q33916802 | ||
Genetic modifiers of atherosclerosis in mice | Q34080318 | ||
LRP: role in vascular wall integrity and protection from atherosclerosis | Q34190034 | ||
Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators | Q35578683 | ||
Tumor necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. | Q38319685 | ||
Vein graft neointimal hyperplasia is exacerbated by tumor necrosis factor receptor-1 signaling in graft-intrinsic cells | Q40503865 | ||
Activation of vascular smooth muscle cells by TNF and PDGF: overlapping and complementary signal transduction mechanisms | Q42473284 | ||
Tumor necrosis factor-alpha stimulates ICAM-1 expression in human vascular smooth muscle cells. | Q42497494 | ||
Actions of tumor necrosis factor on cultured vascular endothelial cells: morphologic modulation, growth inhibition, and cytotoxicity. | Q44045134 | ||
Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice | Q45042448 | ||
Induction of rapid atherogenesis by perivascular carotid collar placement in apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice | Q45875079 | ||
Tumor necrosis factor-alpha promotes atherosclerotic lesion progression in APOE*3-Leiden transgenic mice | Q46380680 | ||
Disruption of tumor necrosis factor-alpha gene diminishes the development of atherosclerosis in ApoE-deficient mice | Q46432117 | ||
Free cholesterol-loaded macrophages are an abundant source of tumor necrosis factor-alpha and interleukin-6: model of NF-kappaB- and map kinase-dependent inflammation in advanced atherosclerosis | Q46434986 | ||
Apolipoprotein E and regulation of cytokine-induced cell adhesion molecule expression in endothelial cells | Q47703061 | ||
RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. | Q54014329 | ||
Tumour necrosis factor and lymphotoxin genes map close to H–2D in the mouse major histocompatibility complex | Q57719163 | ||
Tissue-specific posttranslational modification of rat apoE. Synthesis of sialated apoE forms by neonatal rat aortic smooth muscle cells | Q68489406 | ||
Accelerated atherosclerosis in mice lacking tumor necrosis factor receptor p55 | Q71574059 | ||
Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouse | Q73295343 | ||
Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction | Q73762598 | ||
Peripheral vascular stenosis in apolipoprotein E-deficient mice. Potential roles of lipid deposition, medial atrophy, and adventitial inflammation | Q74071004 | ||
Neointimal hyperplasia rapidly reaches steady state in a novel murine vein graft model | Q78342039 | ||
Lesion progression and plaque composition are not altered in older apoE-/- mice lacking tumor necrosis factor-alpha receptor p55 | Q80591358 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | atherosclerosis | Q12252367 |
P304 | page(s) | 1087-1094 | |
P577 | publication date | 2007-05-01 | |
P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
P1476 | title | Expression of tumor necrosis factor receptor-1 in arterial wall cells promotes atherosclerosis | |
P478 | volume | 27 |
Q37576755 | A pro-inflammatory role of deubiquitinating enzyme cylindromatosis (CYLD) in vascular smooth muscle cells. |
Q33479145 | Absence of p55 TNF receptor reduces atherosclerosis, but has no major effect on angiotensin II induced aneurysms in LDL receptor deficient mice |
Q33947816 | Aging-related atherosclerosis is exacerbated by arterial expression of tumor necrosis factor receptor-1: evidence from mouse models and human association studies |
Q33763278 | An Unsettled Debate About the Potential Role of Infection in Pathogenesis of Atherosclerosis |
Q37383096 | Beta-arrestins regulate atherosclerosis and neointimal hyperplasia by controlling smooth muscle cell proliferation and migration |
Q36802942 | Cytokines and atherosclerosis: a comprehensive review of studies in mice |
Q35640438 | Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets. |
Q37719686 | Emerging role for TNF-α in erectile dysfunction |
Q34427067 | Emerging role of adipokines as mediators in atherosclerosis |
Q41982556 | G protein-coupled receptor kinase-5 attenuates atherosclerosis by regulating receptor tyrosine kinases and 7-transmembrane receptors. |
Q36642535 | Glucagon-like peptide-1 inhibits vascular smooth muscle cell dedifferentiation through mitochondrial dynamics regulation. |
Q30433990 | Glutathione S-transferase-micro1 regulates vascular smooth muscle cell proliferation, migration, and oxidative stress |
Q93107829 | Implications of advanced oxidation protein products (AOPPs), advanced glycation end products (AGEs) and other biomarkers in the development of cardiovascular diseases |
Q48031492 | Inflammation and oxidation: do they improve after kidney transplantation? Relationship with mortality after transplantation. |
Q30454669 | Inflammatory markers in patients with internal carotid artery stenosis. |
Q47630278 | Interleukin-9 mediates chronic kidney disease-dependent vein graft disease: a role for mast cells |
Q28593848 | Kalirin promotes neointimal hyperplasia by activating Rac in smooth muscle cells |
Q24321728 | Kruppel-like factor 15 is critical for vascular inflammation |
Q42182557 | Lobaric Acid Inhibits VCAM-1 Expression in TNF-α-Stimulated Vascular Smooth Muscle Cells via Modulation of NF-κB and MAPK Signaling Pathways |
Q35989018 | Luteolin Inhibits Angiotensin II-Stimulated VSMC Proliferation and Migration through Downregulation of Akt Phosphorylation |
Q33869955 | Mouse aorta smooth muscle cells differentiate into lymphoid tissue organizer-like cells on combined tumor necrosis factor receptor-1/lymphotoxin beta-receptor NF-kappaB signaling |
Q37262841 | Multiple changes in sialic acid biology during human evolution |
Q33396966 | Neuropeptide Y gene polymorphisms confer risk of early-onset atherosclerosis |
Q37121144 | Polymorphisms of the tumor suppressor gene LSAMP are associated with left main coronary artery disease |
Q34296762 | Prevention of vasa vasorum neovascularization attenuates early neointima formation in experimental hypercholesterolemia |
Q37240796 | TNF-alpha infusion impairs corpora cavernosa reactivity |
Q39736808 | TNF-alpha knockout mice have increased corpora cavernosa relaxation |
Q40037411 | The effect of Aloe vera leaf gel on fatty streak formation in hypercholesterolemic rabbits |
Q37568511 | The function of cathepsins B, D, and X in atherosclerosis |
Q38637342 | The protective effect of bee venom on fibrosis causing inflammatory diseases |
Q57818480 | USP20 (Ubiquitin-Specific Protease 20) Inhibits TNF (Tumor Necrosis Factor)-Triggered Smooth Muscle Cell Inflammation and Attenuates Atherosclerosis |
Q36755025 | Ubiquitin-specific Protease 20 Regulates the Reciprocal Functions of β-Arrestin2 in Toll-like Receptor 4-promoted Nuclear Factor κB (NFκB) Activation |
Q36339349 | Vein graft neointimal hyperplasia is exacerbated by CXCR4 signaling in vein graft-extrinsic cells |
Search more.